These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7725254)

  • 21. [Changes in indicators of the antioxidant defense system in patients with ischemic heart disease treated conventionally].
    Syrkin AL; Barsel' VA; Alliluev IG; Kogan IG; Aksiutina MS; Eliubaeva ID; Nesmeianova MA; Drozdov DV
    Klin Med (Mosk); 1996; 74(3):24-7. PubMed ID: 8926695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidants in the treatment of chronic liver diseases: why is the efficacy evidence so weak in humans?
    Lu SC
    Hepatology; 2008 Nov; 48(5):1359-61. PubMed ID: 18697215
    [No Abstract]   [Full Text] [Related]  

  • 23. [Is there an effective therapy for liver diseases? A multicentric clinical study].
    Stoll B; Scholz U; Haase W
    Med Welt; 1976 Apr; 27(15):707-12. PubMed ID: 772360
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of chronic liver diseases].
    Hilt G; Reitmeier H
    Z Allgemeinmed; 1973 Mar; 49(7):327-9. PubMed ID: 4593070
    [No Abstract]   [Full Text] [Related]  

  • 25. [Homeostatic and antioxidant defense enzymes activity in chronic pyelonephritis].
    Tsvettskikh VE; Berdichevskiĭ BA; Sultanbaev VR; Kazeko NI; Ovshinnikov AA; Murychev AV; Tsvettskikh IV; Molokov IuM
    Urologiia; 2000; (3):13-5. PubMed ID: 11186700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of chronic liver disease with lipoic acid].
    Loginov AS; Isakova ZS; Bakumenko MS; Iutanova II
    Klin Med (Mosk); 1967 Aug; 45(8):58-61. PubMed ID: 4887159
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in the content of certain free amino acids in the blood serum in chronic liver disease under the influence of prednisolone therapy].
    Isakova ZS
    Ter Arkh; 1966 Oct; 38(10):80-4. PubMed ID: 5999185
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy of antioxidant therapy in patients with acute and chronic purulent otitis media].
    Khakimov AM; Arifov SS; Faĭzulaeva FN
    Vestn Otorinolaringol; 1997; (5):16-9. PubMed ID: 9432764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antioxidants in experimental and clinical hepatology].
    Khvorostinka VN; Moiseenko TA
    Vrach Delo; 1991 Jul; (7):17-22. PubMed ID: 1771826
    [No Abstract]   [Full Text] [Related]  

  • 30. [The antioxidant system in the dynamic combined treatment of epilepsy patients with traditional anticonvulsant preparations and an antioxidant--alpha-tocopherol].
    Tupeev IR; Kryzhanovskiĭ GN; Nikushkin EV; Bordiukov MM; Iuzefova SM
    Biull Eksp Biol Med; 1993 Oct; 116(10):362-4. PubMed ID: 8117950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of antioxidant therapy on the energy metabolism system and antioxidant defense during the acute period of myocardial infarction].
    Sokolov IM
    Anesteziol Reanimatol; 1995; (5):21-3. PubMed ID: 8533956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review.
    Glantzounis GK; Salacinski HJ; Yang W; Davidson BR; Seifalian AM
    Liver Transpl; 2005 Sep; 11(9):1031-47. PubMed ID: 16123965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antioxidants in the combined therapy of patients with chronic destructive pulmonary tuberculosis].
    Ivanova LA; Pavlova MV; Archakova LI
    Ter Arkh; 1994; 66(11):54-6. PubMed ID: 7900021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity].
    Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A
    Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental clinical study with Silimarin in the treatment of diffuse liver diseases of potentially reversible nature].
    Güemes Díaz F; Pérez Muñóz C; Sallent Herránz J; Arias Vallejo E
    Rev Clin Esp; 1974 Feb; 132(3):263-8. PubMed ID: 4841954
    [No Abstract]   [Full Text] [Related]  

  • 36. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Cancer Chemother Pharmacol; 2008 May; 61(6):933-41. PubMed ID: 17668211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood phospholipids in patients with different clinical manifestations of chronic glomerulonephritis and preserved kidney function].
    Riabov SI; Kulikova AI; Mitrofanova OV
    Ter Arkh; 1995; 67(2):51-4. PubMed ID: 7725261
    [No Abstract]   [Full Text] [Related]  

  • 38. [Enzyme activity of the pentosephosphate pathway of glucose oxidation in chronic liver diseases].
    Alekseeva LM
    Sov Med; 1983; (5):14-7. PubMed ID: 6612454
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug therapy of liver diseases].
    Kautzsch E
    Med Monatsschr; 1971 Jan; 25(1):15-7. PubMed ID: 5546750
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of 5(4) amino 4(5) imidazolcarboxamide ureidosuccinate in inflammatory and degenerative liver].
    Bianchi PG; Saccabusi E
    Minerva Gastroenterol; 1972; 18(4):245-56. PubMed ID: 4614121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.